Transcriptional control of adipocyte formation - PubMed (original) (raw)

Review

Transcriptional control of adipocyte formation

Stephen R Farmer. Cell Metab. 2006 Oct.

Abstract

A detailed understanding of the processes governing adipose tissue formation will be instrumental in combating the obesity epidemic. Much progress has been made in the last two decades in defining transcriptional events controlling the differentiation of mesenchymal stem cells into adipocytes. A complex network of transcription factors and cell-cycle regulators, in concert with specific transcriptional coactivators and corepressors, respond to extracellular stimuli to activate or repress adipocyte differentiation. This review summarizes advances in this field, which constitute a framework for potential antiobesity strategies.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Induction of adipogenesis by a cascade of transcription factors

Exposure of preadipocytes to a cocktail of adipogenic inducers comprised of insulin, glucocorticoids, agents that elevate cAMP (isobutylmethylxanthine), and fetal bovine serum activates expression of several transcription factors that converge on PPARγ. PPARγ then induces C/EBPα expression, and together, these factors oversee terminal adipogenesis.

Figure 2

Figure 2. Role of cell-cycle proteins in regulating adipogenesis

An alternative pathway to that presented in Figure 1 exists whereby E2Fs and associated pocket proteins regulate expression of PPARγ1. Activation of PPARγ2 likely occurs through the induction of C/EBPα by PPARγ1, and C/EBPα then induces PPARγ2 expression. This model is consistent with a role for clonal expansion in promoting adipogenesis. G0, G1, and S correspond to phases of the cell cycle, while GD is a term used to define the growth-arrested state of terminally differentiated cells.

Figure 3

Figure 3. Negative control of adipogenesis

Negative regulators inhibit expression of PPARγ and C/EBPα by attenuating the activity of components of the cascade presented in Figure 1. Several of these negative factors appear to converge on C/EBPβ, supporting its role as a principal regulator of adipogenesis.

Figure 4

Figure 4. Coregulators and adipogenesis

The activity of the adipogenic transcription factors is regulated by association with various corepressors (red boxes) or coactivators (green boxes) at different stages of differentiation of both brown as well as white preadipocytes. The Mediator shown to be associating with PPARγ corresponds to the TRAP (thyroid hormone receptor-associated protein) transcriptional coactivator complex, which interacts physically with PPARγ through the TRAP220 subunit. See text for detailed discussion of the participation of the various protein complexes in controlling each of the transcription factors.

Similar articles

Cited by

References

    1. Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol. 2005;288:276–283. - PubMed
    1. Banerjee SS, Feinberg MW, Watanabe M, Gray S, Haspel RL, Denkinger DJ, Kawahara R, Hauner H, Jain MK. The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis. J Biol Chem. 2003;278:2581–2584. - PubMed
    1. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4:585–595. - PubMed
    1. Batchnarova N, Wang XZ, Ron D. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153) EMBO J. 1995;14:4654–4661. - PMC - PubMed
    1. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA. 2005;102:3324–3329. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources